Literature DB >> 16122848

Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves.

Myung Guk Han1, Sonia Cheetham, Marli Azevedo, Christopher Thomas, Linda J Saif.   

Abstract

We evaluated serum and fecal antibody responses to bovine norovirus (BoNoV) virus-like particles (VLP) and protection against virulent BoNoV in gnotobiotic calves. Calves were vaccinated with two or three doses of VLPs (250 microg/dose) coadministered with oil, mutant E. coli heat-labile toxin (R192G) (mLT) or immunostimulating complexes (ISCOM). Fecal IgA antibody was detected only in calves vaccinated intranasally with VLP+mLT and after challenge, partial protection with delayed, shortened diarrhea (1-2 days) was observed only in these calves. Diarrhea presented from 2 to 6 days in calves vaccinated with VLP with oil or ISCOM and 8 to 9 days in controls. Virus shedding was detected post-challenge by ELISA in all vaccinated calves. All calves recovered from BoNoV infection had high titers of fecal IgA antibodies and were completed protection against challenge. We conclude that only BoNoV VLP+mLT given intranasally stimulated both serum and fecal IgA antibodies and partial protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122848     DOI: 10.1016/j.vaccine.2005.07.071

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Infection of calves with bovine norovirus GIII.1 strain Jena virus: an experimental model to study the pathogenesis of norovirus infection.

Authors:  Peter H Otto; Ian N Clarke; Paul R Lambden; Omar Salim; Jochen Reetz; Elisabeth M Liebler-Tenorio
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

2.  Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus.

Authors:  Jae-Mun Choi; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-02       Impact factor: 11.205

3.  Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.

Authors:  M Souza; M S P Azevedo; K Jung; S Cheetham; L J Saif
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

4.  Pathogenesis of noroviruses, emerging RNA viruses.

Authors:  Stephanie M Karst
Journal:  Viruses       Date:  2010-03-23       Impact factor: 5.818

Review 5.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

6.  Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice.

Authors:  Suvi Heinimäki; Maria Malm; Timo Vesikari; Vesna Blazevic
Journal:  J Immunol Res       Date:  2018-02-28       Impact factor: 4.818

7.  Genomics Analyses of GIV and GVI Noroviruses Reveal the Distinct Clustering of Human and Animal Viruses.

Authors:  Lauren A Ford-Siltz; Lisa Mullis; Yasser M Sanad; Kentaro Tohma; Cara J Lepore; Marli Azevedo; Gabriel I Parra
Journal:  Viruses       Date:  2019-03-01       Impact factor: 5.048

Review 8.  Human Norovirus: Experimental Models of Infection.

Authors:  Kyle V Todd; Ralph A Tripp
Journal:  Viruses       Date:  2019-02-12       Impact factor: 5.048

9.  A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

Authors:  Menira Souza; Veronica Costantini; Marli S P Azevedo; Linda J Saif
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

10.  Pathogenesis of GIII.2 bovine norovirus, CV186-OH/00/US strain in gnotobiotic calves.

Authors:  Kwonil Jung; Kelly A Scheuer; Zhenwen Zhang; Qiuhong Wang; Linda J Saif
Journal:  Vet Microbiol       Date:  2013-11-16       Impact factor: 3.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.